Matinas BioPharma Holdings, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Matinas BioPharma Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Matinas BioPharma Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was -123 %, a 74% decline year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2023 was -89.2 %, a 76.1% decline from 2022.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2022 was -50.7 %, a 30.7% decline from 2021.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2021 was -38.8 %, a 21.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -89.2 -38.5 -76.1% Jan 1, 2023 Dec 31, 2023
2022 -50.7 -11.9 -30.7% Jan 1, 2022 Dec 31, 2022
2021 -38.8 -6.97 -21.9% Jan 1, 2021 Dec 31, 2021
2020 -31.8 +13.2 +29.3% Jan 1, 2020 Dec 31, 2020
2019 -45 +73.9 +62.1% Jan 1, 2019 Dec 31, 2019
2018 -119 -11.2 -10.4% Jan 1, 2018 Dec 31, 2018
2017 -108 +24 +18.2% Jan 1, 2017 Dec 31, 2017
2016 -132 -1.39 -1.07% Jan 1, 2016 Dec 31, 2016
2015 -130 +55.3 +29.8% Jan 1, 2015 Dec 31, 2015
2014 -185 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.